N
Google TrendGREEN CARD (500+) — Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:green card500+power outage near me10000+sony playstation1000+india2000+loki100+hubert hurkacz200+will shipley100+anthony mackie100+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Real-world analyses of th" (30 stories)

Top Headline Story

STORM-PE subset analysis demonstrates correlation between clinical assessments and real-world functional recovery
Lead StoryVascular Newsworld
3d ago

STORM-PE subset analysis demonstrates correlation between clinical assessments and real-world functional recovery

<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxOSVhHV0J2c1pXRVhUWXZOcFdOdTZmR016QXVSQ0NpZTUzVDlPendXdEtfV0Q2LS0zYy1VOGJkVlVLVTNHcnpuSDNmajdwV0pPVHhnRkQ3dThaMk43Tkd4czlDQVNyQThNbnczbVdMTTloazczWjUzMjdYUGhKcmY3TFR1R3FoMlVHOWRCQkRCYXFrRmFucGlIR3JfckR4T0FBcEY4OXZDS3JWZU5MbGxhdjlIT3BJcl9VUkpoS1dvXzdrTF9xTVhlMnV5SV9HNVN2cDNhT1R3?oc=5" target="_blank">STORM-PE subset analysis demonstrates correlation between clinical assessments and real-world functional recovery</a>  <font color="#6f6f6f">Vascular News</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
500+20m ago

green card

Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows

Filter stories
10000+20m ago

power outage near me

LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east

Filter stories
1000+20m ago

sony playstation

PS2 Discs Now Load on Jailbroken PS5 Consoles Through PS5SX2 Emulator

Filter stories
2000+20m ago

india

CJP Protest Live: 'Modi, as PM, is embarrassment to India' - Dipke's 1st reaction after being released

Filter stories

Search Results for "Real-world analyses of th"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026
PR Newswireworld

Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026

<a href="https://news.google.com/rss/articles/CBMiiwJBVV95cUxNVHJ3cVUxNW5RX1I3ZGhQX08wUFI5Sk1XSW9kMHVTRUV3UnZoT21jTG9VWDdpQVFRUFFkYnIxVFo0cXQzWHRRblJ5UzdiX0ZKTGc3SlJIci1zLWIzZVFuYy1kSWx4RkVES0xQZTJOanpyalJnOXFLM2JIOVc3NGhQUzJTQzdlaDFySkp5ZmotRkhneW9TRnNjQTRvQnd2QktxdVJjbHVPbGZnYzJyeFRmZ3l5cWxhTktWTXNJTE96Umg3Z1lzWXV4T1FHaHMwdXVSbkJ6VlRfdlR3SkozUVk3cWNkeFphV0F4MHl0aDVUUy1Oa2U1UC1KRkF1Y0VfbWtNaWJORklVY29Oc1E?oc=5" target="_blank">Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
ATG exposure in T replete transplant for hematological malignancies: Real world analysis from BMT CTN 1202
Natureworld

ATG exposure in T replete transplant for hematological malignancies: Real world analysis from BMT CTN 1202

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBXc1JSN2RWT05CbWJfV0pQd1hadV9VTVlGWU5SWDRubWNaTlJ5aUxfUnJRUTJsMDBiSHFGRFVYaUxIVDFjcEpielhpdjE0WWJuSzJ6dXhLZUNXN2hYVG00?oc=5" target="_blank">ATG exposure in T replete transplant for hematological malignancies: Real world analysis from BMT CTN 1202</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference
BioSpaceworld

Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference

<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxOS3V3NVNQdzc1NldWZnJ2Z3lLU09VSHF5am1oSmdJU28yN1J1dTktbzVVdnVCRk0wcWo5ZjhadlQ1MWJuTm54bEFMU2ZhbkVlV1o2enpPZ0hjRnNtdWFhcEdSZ2stTnZVRHdkdGpFX2RlZ3FZT01DR2Vob1BDVEtrRHFubmlodVNyZEpJeDhIXzc4MFBqVTZueVN2UHE1d0h2azlvSndCUHZJeGdNTTJWYVVhLWdQOTdGTE1IMHZRdExCODlOUXppakU0NkJpa2NSMXBsd3FFYUdpakZIODlYZ1BIOGpYaE9zU3ZMZmlhZw?oc=5" target="_blank">Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
One in Five Lymphoma Patients on R-CHOP Suffers Febrile Neutropenia, Real-World Analysis Finds
Bioengineer.orgworld

One in Five Lymphoma Patients on R-CHOP Suffers Febrile Neutropenia, Real-World Analysis Finds

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPdDRBODRUNTh5YUtIRUtQQmpaQ2RvSFNWZE00cjdrLXBtWXpsdkZsS2ZZYmt2LThHX3NsX1lYSmV5VURJWjBYUlo4RWNNYVJ6YU5rQkpqeWRJX19lUW92UkdQQ0hVQ3JCdWg3ZTVtX0ctbE9ORE5YdFBBRUdUVlFJa2VTTkJjVEFtRm9US0FZYkdkUEhocGVocl9sSGU5TGlWLXViU3o2cllXaEhaT19PclEycUdOQWRGa3c?oc=5" target="_blank">One in Five Lymphoma Patients on R-CHOP Suffers Febrile Neutropenia, Real-World Analysis Finds</a>  <font color="#6f6f6f">Bioengineer.org</font>

Read Full StoryMore like this
Many people with an inherited swelling disorder don't treat every attack
Stock Titangeneral

Many people with an inherited swelling disorder don't treat every attack

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxNVVVGZkdxVmpvYUpUOTBZV3JMUWh2LWVlNzFVbHcxX29UMVY4elpEdmp4NVJsSjNuanZEY0FJdHd6NVU5NFlyU3gwWWcxREU5dVlTRTFIdHBiejc2YjNLYVF3c2lUdV9aalZpUFhYN2NQV3c5d0FlRVZPWDdIdDNRSkhCUkQ2ekxWWEhRNG9IZXU5OWdpcGpST3JlYk1nUC1uWkdObnJhWUhtcG5uYV9FeTJUVU9VTGYwb3NfSmhMYw?oc=5" target="_blank">Many people with an inherited swelling disorder don't treat every attack</a>  <font color="#6f6f6f">Stock Titan</font>

Read Full StoryMore like this
Real-World Evidence and Meta-Analysis of Chemoimmunotherapy Utilization
CancerNetworkworld

Real-World Evidence and Meta-Analysis of Chemoimmunotherapy Utilization

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPdk5BSmlhekNKLUl5M08xZ1RmQ2QyWnFIYnRLOHZYMjhMSDR6NEt6Sk5IbUlUbDRRSUEyUU9yN3ZHc0VxQ1hRNGpXVFk1VVBCSjJWYU56YnQwNm5obGtPXzFpaVhISnltM3owekdxZXRSMUNZelJmN0RlV3ItOGJEUHVtcmhweWZLZ2phMGQ4a1d0RGstRHZhb1VjZmdwOUc2M0NOazdIb0J3QQ?oc=5" target="_blank">Real-World Evidence and Meta-Analysis of Chemoimmunotherapy Utilization</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Real World Analysis of Ideal AI Workloads for NVIDIA Vera on OCI
Oracle Blogstech

Real World Analysis of Ideal AI Workloads for NVIDIA Vera on OCI

<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxNUlVLdkNHYXhSMUN0dnlDUXVrMEZIUHFuZUF4eFRNeDN0UktQamh1anNKVUdMWUpOUlpwQUhGX3MxNU5IQkFXOE8wdkZBbG5zeVRYMWxmYjVvdHVSbDduRkpERWRiZHFMRHpJX2NsZEUwcXZVWnJnLXZNek5kRWFQd1VlUGJmU3lf?oc=5" target="_blank">Real World Analysis of Ideal AI Workloads for NVIDIA Vera on OCI</a>  <font color="#6f6f6f">Oracle Blogs</font>

Read Full StoryMore like this
Real-World Analysis Explores GLP-1 Use and Overall Survival
Targeted Oncologyworld

Real-World Analysis Explores GLP-1 Use and Overall Survival

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPNmNIQnlaU0pYZVVEV2t4eTlYM0dnOWgzRWVEcEZpblN3U25neXNQdjI4S2lZVTF0OWw3RFFUbERxa193WVlUeWx3d201RGxldDVvaklGb1VFa0h4ZHYzazZCZDZTd2djRnY3RXBZR2xueldXbVQxYnJISlBBLTNZUjdKS0VQMUJabm9JeVl5NWlIdnZ5cGkw?oc=5" target="_blank">Real-World Analysis Explores GLP-1 Use and Overall Survival</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
Real-world data support PSA below 0.2 ng/mL as key response threshold in mCSPC
Urology Timesworld

Real-world data support PSA below 0.2 ng/mL as key response threshold in mCSPC

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOcTdfRjBNSmlXZjhWSHcydW1UbVNkQlRraWpac1A2a3lWRGo0RFZTNDQteHV4YzNNdlFJMy1PTXZjM2tHY2pVUHhldkFwRk5rQVpZY0ZaRm5BVVotQ0NOYUYxcWxWM2FjMF9IcWdJTk52UV9PcHg2Wmc4TEJhTW1LT2hwX05WaTVLQlJQTTh6YnpTc3QzeWxSYjZ6SnV6WkZyeUN1ZDFTdEpZdw?oc=5" target="_blank">Real-world data support PSA below 0.2 ng/mL as key response threshold in mCSPC</a>  <font color="#6f6f6f">Urology Times</font>

Read Full StoryMore like this
Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry
Journal of Nuclear Medicineworld

Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE9sZVQ4SHlsU1o4c21BOEhsc0xZUGd3VDFkUWdKYUVxQXptN2NkWkNhSjZIaEZGbm5XUm5SVmxXVEZPMnlKZE5Td3BqTUVVekhyd3ZCOEhMaEhvOW1nemFydkNTb2RaR2JZUDBvRlVtRnhvVEU3Ny03MXRn?oc=5" target="_blank">Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry</a>  <font color="#6f6f6f">Journal of Nuclear Medicine</font>

Read Full StoryMore like this
Talquetamab in R/R Multiple Myeloma: Real-World Analysis From the IMWG Immunotherapy Registry
Oncodailyworld

Talquetamab in R/R Multiple Myeloma: Real-World Analysis From the IMWG Immunotherapy Registry

<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE5LTkprRGhfRlNpR1BJMy10TVZweFhmXzZmSS11alZGcF9rNHhBdEFKNW00TGRwX29BUThDNDM4Mk9HcUl4MWJxeVRGVkRpOU45YTJuSVVDb3hHaGVsQjF6TWlVUXptNnJnRWp2LW42RjhjTFhhUUR5QmpUTW1EUQ?oc=5" target="_blank">Talquetamab in R/R Multiple Myeloma: Real-World Analysis From the IMWG Immunotherapy Registry</a>  <font color="#6f6f6f">Oncodaily</font>

Read Full StoryMore like this
Novo's Ozempic® (semaglutide) 2 mg associated with lower risk of major adverse cardiovascular events (death, heart attack, and stroke) in adults with type 2 diabetes compared to switching to Mounjaro® (tirzepatide), in real-world analysis at EASD
PR Newswireworld

Novo's Ozempic® (semaglutide) 2 mg associated with lower risk of major adverse cardiovascular events (death, heart attack, and stroke) in adults with type 2 diabetes compared to switching to Mounjaro® (tirzepatide), in real-world analysis at EASD

<a href="https://news.google.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?oc=5" target="_blank">Novo's Ozempic® (semaglutide) 2 mg associated with lower risk of major adverse cardiovascular events (death, heart attack, and stroke) in adults with type 2 diabetes compared to switching to Mounjaro® (tirzepatide), in real-world analysis at EASD</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
A real-world propensity analysis of the impact of GLP-1 receptor agonists on cancer therapy-related cardiac dysfunction
Natureworld

A real-world propensity analysis of the impact of GLP-1 receptor agonists on cancer therapy-related cardiac dysfunction

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBCdVRobEd2MkctbDQ5ZFpLdXRtUERjWTFCY0VaakhmbGdVaFlxMEdfaE9POTlfTWF5X2p3SVVFaWluVzlMdlAxdmVwT2hvR3FSX0pwQk9fQlBqZF9Yd3U4?oc=5" target="_blank">A real-world propensity analysis of the impact of GLP-1 receptor agonists on cancer therapy-related cardiac dysfunction</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
92 Abemaciclib After Abemaciclib: A Real-World Comparative Analysis Challenging the Paradigm of Sequential CDK4/6 Inhibitors in Metastatic Breast Cancer
CancerNetworkworld

92 Abemaciclib After Abemaciclib: A Real-World Comparative Analysis Challenging the Paradigm of Sequential CDK4/6 Inhibitors in Metastatic Breast Cancer

<a href="https://news.google.com/rss/articles/CBMilAJBVV95cUxPVVFRdm1ESnZVN0E0ajUyYXhGS0F2VFNjbE5OaXEzNEpKM2Z6aGRBRGJPYkNRQ1otSlF5TnJNMEJQTVZMTEY1R0d5YXdrdnV0Um52eFhtTGQ0LTJJOTJ4TTVuLXpVRE96RHMtRnF2TzFBN3QwTzlsY2dRcmNBODJQcXpZcUtVZUM2RjdvQTJodGdzWFJRa25wSkZsTy1hTnVIZjEtb1ROMGtORVlBUUVIWlc2djNSM0lLZXhIMkRmeklVNjdCWjRFRlhNdDlzMExjVnNXNl80VnJaOUI0Vkk1Z1NoN1ZBaWJkSkN1UUFucVVoZ0taUVFuMGVES1AySFktVEI5S05yal8yOURQeG5tRnJXaGY?oc=5" target="_blank">92 Abemaciclib After Abemaciclib: A Real-World Comparative Analysis Challenging the Paradigm of Sequential CDK4/6 Inhibitors in Metastatic Breast Cancer</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Real-world analysis of androgen receptor inhibitors in US patients with nonmetastatic castration-resistant prostate cancer: DEAR-EXT study
Natureworld

Real-world analysis of androgen receptor inhibitors in US patients with nonmetastatic castration-resistant prostate cancer: DEAR-EXT study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5sRjlFSzZxU1BQNkFOa3V4Uzl3Zk9PV2N0WjduTWhXeTV6VjlxOXlIUVE4WEU3Mm5xTTJXX0pxa1UyRk9IbkZ6RFY2WmlGZDZ0RVBtcmhGZnYydk42R3Aw?oc=5" target="_blank">Real-world analysis of androgen receptor inhibitors in US patients with nonmetastatic castration-resistant prostate cancer: DEAR-EXT study</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Real-world survival benefit of chemotherapy in elderly patients with advanced gastric cancer: a population-based SEER analysis
Natureworld

Real-world survival benefit of chemotherapy in elderly patients with advanced gastric cancer: a population-based SEER analysis

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9mNkNoZGNTMjV5ZER2YzgzdmRtTGdUMk9IdzBiWG1CRmZ6czl6SE1VcVZ3WEktNjdiOU5lMEpoVTNpSjE1ZmtId3hIdzlvcTN3S3RDeFZSLWs1UDI3Y184?oc=5" target="_blank">Real-world survival benefit of chemotherapy in elderly patients with advanced gastric cancer: a population-based SEER analysis</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium | Blood Cancer Journal
Natureworld

Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium | Blood Cancer Journal

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0yNktMcld5Y2ljeFg0WU1EVXVOdk9FUERsVDlpVTBfQ3JQY0tESEFYZkhIYjVyMGtKdlNKRk5PSVU3b2ZYc3kxN2xSZldzRUZOUWhYNVlEckE4dlEwOFQw?oc=5" target="_blank">Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium | Blood Cancer Journal</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Comparison of T-DXd-associated pulmonary toxicity in real-world settings and clinical trials
Natureworld

Comparison of T-DXd-associated pulmonary toxicity in real-world settings and clinical trials

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE44QjRRckZ6amh5ZUVmTVZjR0xJMFJJZkFVSkpZRWM4TWV1dUlpcWtqXzItOGEwRGFDTzNRYy1XVkNpNFljVGh5RERCWXBJV0lQa056eVlGbTJUWFRhcEUw?oc=5" target="_blank">Comparison of T-DXd-associated pulmonary toxicity in real-world settings and clinical trials</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States
Natureworld

Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE10c3lGVGZfdVFXNVI0bGhwZW9XVkxVVldSakxncEFXcjk1Z0JXb283MDdnVDYzdG9NZEM1dkpWOU4tWXB5amtEVFk4MklhNGJla2JFQXZsSllnWFYzU19z?oc=5" target="_blank">Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United States</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Real-World Analysis Establishes OS Advantage With Apalutamide Plus ADT vs Darolutamide in mCSPC
OncLiveworld

Real-World Analysis Establishes OS Advantage With Apalutamide Plus ADT vs Darolutamide in mCSPC

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxQVlBobmhIZi05TnVlLUJfMTgyTk5rbnd6ejlDY2xXVW9VdVRBdWc3NXp5QWM2T2hBYVd5SHhiR3IyTXVvTmt1NlQ1Y1VJbnl4bEZxZF83UF9PZGc1WXhLYlJ0a1NEREQtSW1DTXU2VkJsRW9UbDhfdWRxYVNmQloyUmxHVmlsci1OUGJHYVFDWXkyd1FEeWdtazNNT2taamRuRXRsN0F6R0tpaFN6b1VwNXlVVndzdVBBUVFCbmk3M3dtQQ?oc=5" target="_blank">Real-World Analysis Establishes OS Advantage With Apalutamide Plus ADT vs Darolutamide in mCSPC</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
Real-World Analysis of Lutetium-177 in mCRPC by Taxane Treatment Sequence - Micah Ostrowski
UroTodayworld

Real-World Analysis of Lutetium-177 in mCRPC by Taxane Treatment Sequence - Micah Ostrowski

<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxPa0l6b1U2TDNCUVVRVWVHU0xodmhDcEJtdHhBT3dzRldkdUdEMnJESVdSSjF2cnZKZ0l3TUtWaFNXdm1PWGRuZF9jUDkwR3lDVlZCYXZHYmZEdGJ1WDRKMkVSZndSQWNteEF6SEZfVVhZZXFTelBQT2dmWnJSMGlpMjNfR3B1Nzl3bl8wMU9TS3ZhcUhFanItd1V1S01OWmZYeDFtazhKTlhNZG83OWFBaGxCVm4xd1pFb3ViWHlJQ08zS01JX2hza1o3MFFsXzZxdGZxWTRCTTFLY1BNQjA0NVJ4X25rRDhHZFZQNHNJbw?oc=5" target="_blank">Real-World Analysis of Lutetium-177 in mCRPC by Taxane Treatment Sequence - Micah Ostrowski</a>  <font color="#6f6f6f">UroToday</font>

Read Full StoryMore like this
Real-World Analysis Reiterates Importance of Performance Status, Toxicity Management With Mirvetuximab Soravtansine in Recurrent Ovarian Cancer
OncLiveworld

Real-World Analysis Reiterates Importance of Performance Status, Toxicity Management With Mirvetuximab Soravtansine in Recurrent Ovarian Cancer

<a href="https://news.google.com/rss/articles/CBMiggJBVV95cUxOZEg2NkRsTkxHOUdaX3U3N1NsekJsbjR1NDc4ejJWcG5zb2JpdVVJbDNwYmRMTkNycS1mWmpsRTBjYjN0Q0JQd3FndUlrcGVoYTBoN05kQVBnZGxfTzcwZTJmUjJFSFhtclVITV9fY0tIRWwxNEFfbm5Nb1Q2T2NHRXN2OUpIMWJ4VklhRk9NaWlfYm5IRHRwbVFObVdiZGRrWnA4UWtHdEhRMFNEUk1lRi03YmJYR0xObXNmeEdMLTlCbzBVeGxGUlRYMHZjUXR2VTVrcXF6LVFCRnBBRzBwbTlLTVljcFlXb2RaeXVDVVBKREtjTXZ3N0E1dXVXUUJIWWc?oc=5" target="_blank">Real-World Analysis Reiterates Importance of Performance Status, Toxicity Management With Mirvetuximab Soravtansine in Recurrent Ovarian Cancer</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
144 A Comparative Analysis of Pregnancy-Related Breast Cancer Outcomes Versus Non-Pregnant Breast Cancer Patients—A TriNetX Real-World Analysis
CancerNetworkworld

144 A Comparative Analysis of Pregnancy-Related Breast Cancer Outcomes Versus Non-Pregnant Breast Cancer Patients—A TriNetX Real-World Analysis

<a href="https://news.google.com/rss/articles/CBMiigJBVV95cUxNZ29sd3JNQnF5VnlRbmRLcjhfRjFMWDJJSHMwRWdERmVCUmZSUWFNbTRJVFhFbHUwbzVvWGowdmNaOVhGS252OEtIbVFrTXdBaERxT0hEbGNEVFo2ZkFNa1lOLXRobzlvMEllU1B4LUdGSUdWRWF6WWVDN1VFQ0xXaE5Hdlh1SF9rdmI3LV8tenMtSDJZc1Q4Nld2d2hwRTQ4Z19PMEZuRzdPemcxMmNfdVlxSFE1QzVKeVg5NDhLYWE2R3lCaGlYOUQ5aGlmdldnRmE5RU52MFg5Z19QR0w3c1NzbFpOcTJwN2NmTjhTWmRwM0NPWHRWQkR1bW84bU5TVlRocG1RMENwUQ?oc=5" target="_blank">144 A Comparative Analysis of Pregnancy-Related Breast Cancer Outcomes Versus Non-Pregnant Breast Cancer Patients—A TriNetX Real-World Analysis</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Real-world analysis of multiple myeloma treatments in England using the Cancer Analysis System registry
Natureworld

Real-world analysis of multiple myeloma treatments in England using the Cancer Analysis System registry

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB2TG0tS3ZILUtwZXAxSnF2NG95MldEMDdyUnU2TUdXNmJvejBZeGpWdm1QcWp3WmRua2puRy15TzZNRHBncDM4cGIxdlpaQW9GVDJtT2pkZGtTbWFZSXhZ?oc=5" target="_blank">Real-world analysis of multiple myeloma treatments in England using the Cancer Analysis System registry</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Tarlatamab Demonstrates Superior Intracranial and Systemic Efficacy in Relapsed Extensive-Stage Small Cell Lung Cancer: Results from the Phase 3 DeLLphi-304 Trial and Real-World Analyses
Onco'Zineworld

Tarlatamab Demonstrates Superior Intracranial and Systemic Efficacy in Relapsed Extensive-Stage Small Cell Lung Cancer: Results from the Phase 3 DeLLphi-304 Trial and Real-World Analyses

<a href="https://news.google.com/rss/articles/CBMitgJBVV95cUxOa1ZuU1JqOVZ4NDJWR0FnSjJLbWU5QW9HTXZCZzhaaEw5S08wMWxBUXpYT3EyVjljU1NEdS1xV3o4bUF1RXNQNVcyZTJjVzU5RjRQb0NKNDdGMXhBQ1I0UEhqRWNMMjh0N2dqbEFYcVBWS2V0eUs2VUQwUFE2UnVqRkZqX2wwRzFYRjhENU5MNmtrMUUwS25sVXhIZWRBa0VUZWZsQjJrYXhzbHFzQzlwLVhDMjdyVExuS014c1Y1RThsM0RBdlhGc1RqZy10R19yNENRVFQySmZiVE9GM3V2dkh6bnN2S3FGU1VYRWxJMmh4VmtJM1g3cFhsSHR5dEVMcnNLNE1vM1QwOTRBWGxGbDg0Y2liLXNDUkdmcWFwUGVPanN6aTE4eVlrVjZBalgyTTlMVkZn?oc=5" target="_blank">Tarlatamab Demonstrates Superior Intracranial and Systemic Efficacy in Relapsed Extensive-Stage Small Cell Lung Cancer: Results from the Phase 3 DeLLphi-304 Trial and Real-World Analyses</a>  <font color="#6f6f6f">Onco'Zine</font>

Read Full StoryMore like this
A lung cancer target stayed largely stable after treatment. Whitehawk is testing a targeted drug.
Stock Titanworld

A lung cancer target stayed largely stable after treatment. Whitehawk is testing a targeted drug.

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPRm5ISkZVeWRCYnY3eE1ONjlSODF3X3dablM5TEpuMlB0RVp3Zmk5dm5DR001NGJiZDlieEo1bjVGUEtFZnNvTEhiemEwRXRhZl9DU2loaEs0ZjhJUGRrU29pdW5COUV6Z1JxWnVLaHV0czkzVFVqYUtoVkNTT1pJYWV4TUdsbFZFVnpEcXlYMjFqdW9sQ21teWRCNWlLQ3hUeEV0RkNHcE5tSEd2MVZFeUFzclJvbzNuTWJzNnZFcw?oc=5" target="_blank">A lung cancer target stayed largely stable after treatment. Whitehawk is testing a targeted drug.</a>  <font color="#6f6f6f">Stock Titan</font>

Read Full StoryMore like this
First-Line Zanubrutinib Is Associated With Improved Real-World Efficacy in Older Patients With CLL
OncLiveworld

First-Line Zanubrutinib Is Associated With Improved Real-World Efficacy in Older Patients With CLL

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxOUm5KWUhYcHNXT041Q0dhYnd3TGFXTm55azl4RVVFUFZ1WDRtalFQSy10Yk1EOERtSEUtQnJwRlE0NEVhRUt2NGkyZ0t2LW1kczltd01FTkpMeUJidmVkNjFQWWF0Q0NONFRVa2FWcG90MklxOTVZcTNBX19IajkzemNLdkgyU3hocTFnd2FURXh4TG9DUkJQT2NySjlHVnYwRE10NDlZVURNeFh3QlNGUDBtdE9fdjNGSjlscm5qWDRxY2RjTkE?oc=5" target="_blank">First-Line Zanubrutinib Is Associated With Improved Real-World Efficacy in Older Patients With CLL</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
No HIV Infections Seen With Cabotegravir PrEP in Real-World Study
Contagion Liveworld

No HIV Infections Seen With Cabotegravir PrEP in Real-World Study

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxPZ3RJQnBJS25vaXo0WTMtUlZpejhLNGJzdHhseTNUbnF0RS1OOVZYTkFCUlVKd0h6R0NfRHZwUGU5VEJZZzBoa05CcEdiUE43aU9XUUgxazB2SEdaSjhWUUNJN0V2VWpNeTBmM19fTjdOdllpaThSaEp6MkFpYW1TWERyeFBEUFg2MXBtS3ozVnk?oc=5" target="_blank">No HIV Infections Seen With Cabotegravir PrEP in Real-World Study</a>  <font color="#6f6f6f">Contagion Live</font>

Read Full StoryMore like this
Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA® (valbenazine) Capsules Compared to AUSTEDO XR
PR Newswiretech

Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA® (valbenazine) Capsules Compared to AUSTEDO XR

<a href="https://news.google.com/rss/articles/CBMi1gJBVV95cUxOVnR0YVZrZ0doUlJvUmxEWTVnRmNldWRhdU8xejlhOE5mYWlLQ20zblRQbmViOVhGQ1dFTU54STlSY2RuUWQwa1lBSFFFREVCR2pBdHZyM0xuaFVOS2MweEJ6Z3Q2RHJ6WDBsbHBhM0ZOazA5SzF3cHpqdElWaGF0dlZTWEtTLXVPeUI2TWRaMTlpb3pPUVBrRURnUlhXUnZEcm5OOThtM0tpYkFubkFUenQxZlo0dllZZXlYNDVCdEhIam80LXRWaEFJMEpNVC1XQURLOHpGZjExbUNoeXBuNk1SZ1Y2ZnZab0tHZURmM3JSQXgxeWROY2k3SVJfa3lOM0xORWRIQ1RIWGpJWG54QV9UNER1eTRBZXhYMkw5ZDRDdmgtRXlWd1dWSTAwdVZFSGRneE9jZElDUHlrWlptQ0tyS2VaX0RidV9lalpiTkZKbDNDWGc?oc=5" target="_blank">Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA® (valbenazine) Capsules Compared to AUSTEDO XR</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
"Real-world analyses of th" — Live Google News Trends & Headlines